These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35059132)

  • 1. The BASHY Platform Enables the Assembly of a Fluorescent Bortezomib-GV1001 Conjugate.
    Baldo S; Antunes P; Felicidade JF; Santos FMF; Arteaga JF; Fernandes F; Pischel U; Pinto SN; Gois PMP
    ACS Med Chem Lett; 2022 Jan; 13(1):128-133. PubMed ID: 35059132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electronic and Functional Scope of Boronic Acid Derived Salicylidenehydrazone (BASHY) Complexes as Fluorescent Dyes.
    Alcaide MM; Santos FMF; Pais VF; Carvalho JI; Collado D; Pérez-Inestrosa E; Arteaga JF; Boscá F; Gois PMP; Pischel U
    J Org Chem; 2017 Jul; 82(14):7151-7158. PubMed ID: 28696691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Three-Component Assembly Promoted by Boronic Acids Delivers a Modular Fluorophore Platform (BASHY Dyes).
    Santos FM; Rosa JN; Candeias NR; Carvalho CP; Matos AI; Ventura AE; Florindo HF; Silva LC; Pischel U; Gois PM
    Chemistry; 2016 Jan; 22(5):1631-7. PubMed ID: 26691630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-selective installation of BASHY fluorescent dyes to Annexin V for targeted detection of apoptotic cells.
    Cal PM; Sieglitz F; Santos FM; Parente Carvalho C; Guerreiro A; Bertoldo JB; Pischel U; Gois PM; Bernardes GJ
    Chem Commun (Camb); 2016 Dec; 53(2):368-371. PubMed ID: 27935613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyanine-Like Boronic Acid-Derived Salicylidenehydrazone Complexes (Cy-BASHY) for Bioimaging Applications.
    Santos FMF; Domínguez Z; Fernandes JPL; Parente Carvalho C; Collado D; Pérez-Inestrosa E; Pinto MV; Fernandes A; Arteaga JF; Pischel U; Gois PMP
    Chemistry; 2020 Nov; 26(62):14064-14069. PubMed ID: 32449571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering the BASHY Dye Platform toward Architectures with Responsive Fluorescence.
    Felicidade J; Santos FMF; Arteaga JF; Remón P; Campos-González R; Nguyen HC; Nájera F; Boscá F; Ng DYW; Gois PMP; Pischel U
    Chemistry; 2023 Jun; 29(31):e202300579. PubMed ID: 36972045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BASHY Dye Platform Enables the Fluorescence Bioimaging of Myelin Debris Phagocytosis by Microglia during Demyelination.
    Pinto MV; Santos FMF; Barros C; Ribeiro AR; Pischel U; Gois PMP; Fernandes A
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid shell and disulfide-crosslinked core micelles for in vivo targeted delivery of bortezomib for the treatment of multiple myeloma.
    Gu Z; Wang X; Cheng R; Cheng L; Zhong Z
    Acta Biomater; 2018 Oct; 80():288-295. PubMed ID: 30240956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circularly Polarized Luminescence of Boronic Acid-Derived Salicylidenehydrazone Complexes Containing Chiral Boron as Stereogenic Unit.
    Jiménez VG; Santos FMF; Castro-Fernández S; Cuerva JM; Gois PMP; Pischel U; Campaña AG
    J Org Chem; 2018 Nov; 83(22):14057-14062. PubMed ID: 30365318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEGylated Dendrimer Mediated Delivery of Bortezomib: Drug Conjugation versus Encapsulation.
    Sahoo RK; Gothwal A; Rani S; Nakhate KT; Ajazuddin ; Gupta U
    Int J Pharm; 2020 Jun; 584():119389. PubMed ID: 32380027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotinylated HPMA centered polymeric nanoparticles for Bortezomib delivery.
    Rani S; Sahoo RK; Nakhate KT; Ajazuddin ; Gupta U
    Int J Pharm; 2020 Apr; 579():119173. PubMed ID: 32097684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system.
    Dou QP; Zonder JA
    Curr Cancer Drug Targets; 2014; 14(6):517-36. PubMed ID: 25092212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foe to Friend: Supramolecular Nanomedicines Consisting of Natural Polyphenols and Bortezomib.
    Wang C; Sang H; Wang Y; Zhu F; Hu X; Wang X; Wang X; Li Y; Cheng Y
    Nano Lett; 2018 Nov; 18(11):7045-7051. PubMed ID: 30264573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycine-Poly-L-Lactic Acid Copolymeric Nanoparticles for the Efficient Delivery of Bortezomib.
    Rajoria S; Rani S; Chaudhari D; Jain S; Gupta U
    Pharm Res; 2019 Sep; 36(11):160. PubMed ID: 31520196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing the efficiency of bortezomib conjugated to pegylated gold nanoparticles: an in vitro study on human pancreatic cancer cells and adenocarcinoma human lung alveolar basal epithelial cells.
    Coelho SC; Almeida GM; Santos-Silva F; Pereira MC; Coelho MA
    Expert Opin Drug Deliv; 2016 Aug; 13(8):1075-81. PubMed ID: 27087021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bortezomib-loaded solid lipid nanoparticles: preparation, characterization, and intestinal permeability investigation.
    Mahmoudian M; Valizadeh H; Zakeri-Milani P
    Drug Dev Ind Pharm; 2018 Oct; 44(10):1598-1605. PubMed ID: 29874944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of bortezomib-adapted I-45 mesothelioma cells.
    Zhang L; Littlejohn JE; Cui Y; Cao X; Peddaboina C; Smythe WR
    Mol Cancer; 2010 May; 9():110. PubMed ID: 20482802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of hollow mesoporous silica nanospheres to encapsulate bortezomib and improve efficacy for non-small cell lung cancer therapy.
    Shen J; Song G; An M; Li X; Wu N; Ruan K; Hu J; Hu R
    Biomaterials; 2014 Jan; 35(1):316-26. PubMed ID: 24125776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and Intracellular Trafficking of Lipid-Drug Conjugate Nanoparticles Containing a Hydrophilic Antitubercular Drug for Improved Intracellular Delivery to Human Macrophages.
    Pandit S; Roy S; Pillai J; Banerjee S
    ACS Omega; 2020 Mar; 5(9):4433-4448. PubMed ID: 32175491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catechol polymers for pH-responsive, targeted drug delivery to cancer cells.
    Su J; Chen F; Cryns VL; Messersmith PB
    J Am Chem Soc; 2011 Aug; 133(31):11850-3. PubMed ID: 21751810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.